Dupixent® (dupilumab) SmPC updated with long-term data reinforcing well-established safety profile in adults with moderate-to-severe atopic dermatitis

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing